Not a good buy right now for an impatient entry: price is extended and technically overbought after a sharp run.
Risk/reward at $101.11 pre-market is skewed: upside to the next resistance zone ($104.93) is limited versus downside back toward the pivot/support ($93.35).
Options positioning is extremely call-heavy and IV is elevated into earnings (2026-02-12 pre-market), which often coincides with choppy price action.
MACD: Histogram +1.64 and expanding → momentum is still positive.
RSI(6): 92.6 → extremely overbought; chasing here statistically favors a pullback/consolidation.
Key levels:
Pivot/support: ~93.35 (more meaningful support)
Near-term support: ~100.51 (R1 now acting as breakout retest level)
Resistance: ~104.93 (R2)
With pre-market at ~101.11 (above R1 100.51), the stock is in a breakout area, but the overbought RSI suggests a higher probability of a near-term fade than a clean continuation.
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Sentiment: Extremely bullish/speculative (Put/Call OI ratio 0.06; Put/Call volume ratio 0.01).
Activity: Volume 708 vs 30D avg surge (today vs avg ~544.6%) → unusual attention.
Volatility pricing: 30D IV 61.32 vs historical vol 39.81; IV percentile 88.84 → options are pricing elevated movement (often earnings-related).
Interpretation: Traders are leaning strongly bullish, but the very high IV suggests the “easy” upside may already be priced in near-term.
Profitability: Net income $7.463M, down -103.19% YoY; EPS $0.18, down -103.38% YoY → earnings power deteriorated sharply versus last year.
Gross margin: 39.48%, up +70.17% YoY → margin improved materially, but it has not translated into higher bottom-line results (yet).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
2026-02-03: Roth Capital maintains Buy and raises price target to $110 (from $105).
Wall Street pro view (pros): Stabilizing manufacturing backdrop; product initiatives (automation/material cleaning/medical/directed energy) seen as stronger growth drivers than legacy metal cutting/welding.
Wall Street con view (cons): Recent financials show earnings pressure (net income/EPS down sharply YoY), so the bull case needs confirmation via execution and upcoming earnings/guidance.
Positioning/trading flows: Hedge funds neutral (no significant trend last quarter); insiders neutral (no significant trend last month); no recent Congress trading data available.
Wall Street analysts forecast IPGP stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IPGP is 99 USD with a low forecast of 92 USD and a high forecast of 105 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast IPGP stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for IPGP is 99 USD with a low forecast of 92 USD and a high forecast of 105 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
3 Buy
2 Hold
0 Sell
Moderate Buy
Current: 99.300
Low
92
Averages
99
High
105
Current: 99.300
Low
92
Averages
99
High
105
Roth Capital
NULL -> Buy
maintain
$105 -> $110
AI Analysis
2026-02-03
New
Reason
Roth Capital
Price Target
$105 -> $110
AI Analysis
2026-02-03
New
maintain
NULL -> Buy
Reason
Roth Capital raised the firm's price target on IPG Photonics to $110 from $105 and keeps a Buy rating on the shares. The firm is constructive on IPG Photonics shares as it sees continued stabilization across manufacturing industries and believes that key product initiatives in areas such as automation, material cleaning, medical, and directed energy are outpacing traditional metal cutting and welding applications, the analyst tells investors in a research note.
Citi
Jamie Wang
Sell -> Buy
upgrade
$68 -> $105
2025-11-05
Reason
Citi
Jamie Wang
Price Target
$68 -> $105
2025-11-05
upgrade
Sell -> Buy
Reason
Citi analyst Jamie Wang double upgraded IPG Photonics to Buy from Sell with a price target of $105, up from $68, following the Q3 report. The firm sees the company's business recovery in Q3 continuing due to improving demand for welding and micromachining. IPG posted positive revenue growth year-over-year after 12 consecutive quarterly declines, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for IPGP
